Device innovations, demographics and hospital austerity are all factors helping to drive the global medical device market to more than $300 billion, according to healthcare market research publisher Kalorama Information. In its report, " The Global Market for Medical Devices," Kalorama Informations analysts predict a $312 billion medical device market in 2011.
"There are many drivers on the upside for medical devices," says Kalorama Informations publisher, Bruce Carlson. "Demand for healthcare services in emerging nations, the need for reducing hospital stays and the aging world population are the key ones."
The market for medical devices is vast and, in Kalorama Informations report, products as different as complex MRI machines, laparoscopic surgical equipment, wheelchairs and medical gloves are included in the category.
Kalorama sees roughly 4 percent to 6 percent growth for the next few years in the global device market, which was valued at $290 billion in 2009. Growth has been slow the past few years, according to the report, given the world recession. But as the economy recovers and new middle class customers in emerging markets demand better healthcare services, the report predicts the pace of revenue growth to increase. According to Carlson, the average growth rate belies that in some categories growth is much higher than the average discussed in the report.
"Some categories of medical devices are commoditized and competition will hold prices in check, while in other areas revenues will flourish," Carlson says. "Patient monitoring, oxygen systems, home dialysisanything that can reduce hospital stays and keep patients at home with their familyare seeing faster revenue growth."
There are hundreds of companies operating in the global medical device market, but according to the report, the majority of revenues will be earned by 30 of the top companies, among them: Johnson & Johnson, Siemens Healthcare, Medtronic, GE Healthcare and Baxter.
Kalorama Informations estimates are based on industry interviews, a review of the firms own previous research into specific device markets and annual reports of major companies.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.